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Abstract 
While increased attention has focused on human exposure to flame retardant 
chemical additives in residential settings, little attention has focused on exposure and 
health risks in health care settings. More stringent flammability standards in these 
settings may result in increased use and exposure to these potentially toxic compounds in 
vulnerable populations including sick patients, the elderly, children and pregnant women. 
The goal of this project was to collect more information on the use and potential exposure 
to flame retardant chemicals in health care environments. To accomplish this goal, 
manufacturers of health care products were surveyed for information about the 
construction of their products and application of flame retardant chemicals.  In addition, 
chemical analyses were conducted on both samples of furniture foam and indoor dust 
samples collected from hospitals as a means of estimating potential exposure and risks to 
hazardous flame retardants. Very few companies responded to the survey, resulting in 
limited responses, therefore, more focus was placed on chemical analyses in samples of 
healthcare products and hospital dust particles. Flame retardant chemicals were detected 
and quantified in 7 furniture products including a hospital sofa, patient beds and a baby 
bed.  Several different flame retardant chemicals were also detected and quantified in 22 
dust samples from 15 different hospitals.  The range of total polybrominated diphenyl 
ether (PBDE) concentrations in dust samples was 1,080 to 75,800 ng/g dry dust and the 
total organophosphate flame retardants (OPFR) concentrations ranged from 2,290 to 
108,000 ng/g dry dust. On average, the levels of OPFR in hospital dust were equivalent to 
reported levels in residential dust samples while the levels of PBDEs and a newer-use 
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flame retardant commercial mixture, Firemaster® 550 (FM 550), in hospital dust was 
higher than reported in residential environments. Estimates of exposure were made based 
on these measured concentrations and US EPA human dust ingestion data. Based on 
these findings, exposure to flame retardant chemicals in health care settings could be 
higher for vulnerable and sick populations, and suggests further research may be needed 
to assess potential health risks. 
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Introduction  
Flame retardant chemical additives are widely applied to various polymers and 
textiles found in electrical and electronic equipment, furniture, and even construction 
materials to meet flammability standards (WHO,1994). These chemicals typically work 
by significantly reducing the time it takes for a material to combust, or delaying the rate 
at which a product will burn. Despite the potential benefits in delaying fire propagation 
and saving lives, these chemical additives are known to leach into the environment and 
accumulate both in the ecosystem and in human tissues (Soechitram, 2004) (Schecter, 
2004). Several research studies have found increasing levels of flame retardants in human 
tissues over the past few decades, and levels in the United States population are 
considerably higher compared to levels measured in the European Union (EU) (Hites, 
2004) (Hale, 2003).  Furthermore, human and animal studies have observed the 
association of adverse health effects to flame retardant exposure, increasing public health 
concerns about flame retardants applications in consumer products (Sjödin, 2004) 
(Ikonomou, 2002) (Norstrom, 2002).  
 
Flame retardants application   
The more than 100 types of flame retardant chemicals can be generally divided into four 
classes: halogenated organic, organo-phosphorus, nitrogen-based and inorganic flame 
retardants. Brominated flame retardants (BFR), especially PBDE, have had a large 
market proportion of the halogenated organic market. They are additive chemicals, 
implying that they are not chemically bonded to the raw material in the products, and 
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they can continuously leach into the environment during the product lifetime. In addition, 
their persistence and bioaccumulation behavior contribute to their ubiquitous presence in 
the environment (Birnbaum, 2004). The measured PBDE concentrations in human tissue 
are 17 times higher in the United States than levels in Europe.  For example, 
concentrations in people from Europe were about 2ng/g lipid and concentrations in 
people from United States were about 35 ng/g lipid (Hites, 2004).  The higher levels in 
the US than in EU could be attributed to the stricter flammability standards for residential 
furniture, in which California’s Home Furnishings Technical Bulletin 117 is the major 
standard (Phil Brown, 2011). Reported adverse effects of some flame retardants include 
endocrine disruption, neurotoxicity, suspect carcinogenicity and developmental effects. 
However, different flame retardants have different effects based on their respective 
structures and properties (Birnbaum, 2004) (Stapleton, Sharma, Getzinger, & Ferguson, 
2012) (Darnerud, 2003).  
 
PBDEs have historically been used in polyurethane foam, electronics and some textiles. 
With the increasing demand of these materials in consumer products, BFRs in 1990 had a 
market of 145,000 metric tons and doubled to 310,000 metric tons in 2000 (BSEF, 2006). 
Deca-BDE, penta-BDE and octa-BDE are three different commercial mixtures of PBDEs, 
and were named based on their respective bromination level. In 2001, deca-BDE 
comprised 83.3% of the global PBDE market, while penta-BDE was 11.1% and octa 
BDE 5.6% (Renner, 2004). Penta-BDE and octa-BDE were banned in EU in 2004, while 
in the US, the manufacturer of pentaBDE voluntarily agreed to phase out the chemicals in 
2005. Even with the phase out, the continuous use of old furniture, either by individuals 
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or by recycling, contributes to continuous emissions of PBDE into the environment and 
human exposure (La Guardia, 2006).  
 
As PBDEs were restricted, new flame retardant chemicals have increasingly been used 
and are now detected in indoor environments (Stapleton, et al., 2009) (Wensing, 2005). 
OPFR have become a popular replacement for PBDE. In Europe, the production and 
application rate of OPFR was initially larger than PBDE. But more recent studies have 
now found higher OPFR levels compared to PBDE in indoor environments (Reemtsma, 
2008) (Meeker, 2010). The major types of OPFR detected in the indoor environment 
include: tris(1-chloro-2-propyl)phosphate (TCPP), tris(1,3-dichloroisopropyl) phosphate 
(TDCPP),  triphenyl phosphate (TPP) and tris(2-chloroethyl)phosphate (TCEP). The 
more widely used chemicals are TPP and TDCPP since they are also used as plasticizers 
(Stapleton H. M., 2005) (Birnbaum, 2004) (Wu, 2007) (Sjodin, Patterson, & Bergman, 
2003). Another flame retardant chemical mixture used as a replacement for pentaBDE is 
FM 550, which contains two brominated compounds, 2,3,4,5-tetrabromo-
ethylhexylbenzoate (TBB) and 2,3,4,5-tetrabromo-bis(2-ethylhexyl) phthalate (TBPH). 
These two chemicals have been detected in some environmental settings though 
information about their toxicity and health effects is limited (Bearr, 2010).  
 
Human Exposure Pathways 
Human can be exposed to flame retardants through dietary intake, inhalation, dermal 
absorption, or inadvertent ingestion of dust particles (Daso, 2010). Because halogenated 
and organo-phosphorus flame retardants are ubiquitous and lipophilic, dietary intake 
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from meat, fish or chicken can contribute to exposure (Daso, 2010). A study found that 
serum PBDE levels in vegetarians were 23% lower than in omnivores in the United 
States (Fraser, 2009). Several European studies have observed correlations between fish 
or meat ingestion and flame retardants concentrations in the body (Daso, 2010). The time 
spent in some microenvironments such as living rooms, office rooms or cars can 
contribute most to exposure since people may stay in those environments for most of the 
time (Daso, 2010). In addition, due to the continuous leaching and persistence of most 
flame retardants, indoor dust is a sink for these chemicals (Daso, 2010). 
 
However, exposure pathways are different for people in the US when compared to people 
in the EU or Asia. Among the general US population, inhalation and ingestion of indoor 
dust, are suggested to be the primary exposure pathway to PBDEs (Lorber, 2008). 
According to this review, exposure to house dust from various studies range from 3 
ng/day (assuming 1 mg/day dust ingestion) to 400 ng/day while exposure due to food 
ingestion was only 0.5-2.0 ng/day in the US population. Increasing PBDE levels in 
human serum was found to be associated with increasing PBDE detected in household 
dust (Johnson et al. 2011; Stapleton et al. 2012). Thus, the analyses of flame retardants 
concentrations in dust is a key factor in determining human exposure and health risks to 
flame retardants in these environments.  
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Mechanism of toxicity and health concerns  
PBDE health concerns 
Several animal studies suggest that PBDEs might cause endocrine disruption, especially 
thyroid hormone disruption and neurodevelopmental alterations. Because of the similar 
structure of PBDE and their hydroxylated metabolites to thyroid hormones, which 
include triiodothyronine (T3) and thyroxine (T4), PBDE and their metabolites have been 
found to compete with T3 and T4 in binding to thyroid hormone transport proteins or 
thyroid hormone receptors (Meerts, 2000). Rats and mice with a sub-chronic dietary 
exposure (14 days) to pentaBDE were observed to have decreased T4 (Fowles, 1994) 
(Darnerud, 2003). Another study indicted that the administration of 7 mg/kg pentaBDE 
and 5 mg/kg octaBDE would result in a 20% decrement in serum T4 (Zhou, 2001). Two 
mechanisms were suggested. First, PBDEs may induce liver enzymes such as P450 1A1, 
cytochrome P450 2B and UDP-glucuronosyltransferases (UGT), which increases the 
conjugation and excretion of T4. Second, as is stated before, with the similar structure f 
PBDEs and their metabolites to thyroid hormones, they could bind to the hormone 
transporter (i.e., transthyretin). Transthyretin (TTR) is important in transporting T4 from 
mother to fetus and in transfer across the blood-brain barrier. Thus, the preferable binding 
of hydroxyl-PBDEs may also lead to its bioaccumulation in fetal brain (McDonald, 
2002). 
 
Other studies have observed learning and behavioral deficits in mice exposed to PBDEs 
and the deficits worsen with aging (McDonald, 2002). The effects on neurodevelopment 
may result from thyroid disruption since thyroid hormones regulates a series of brain 
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development activities such as neuronal migration, differentiation and neuronal 
connectivity(Porterfield, 2000). Alternatively, this may also occur from disruption of 
secondary messengers and alterations in neurotransmitter systems (McDonald, 2002).  
 
In a rodent bioassay study by the National Toxicology Program (NTP), liver neoplastic 
nodules were associated with high doses of decaBDE administered to rats. Hepatocellular 
carcinomas, thyroid gland follicular cell adenomas and carcinomas were also observed 
(NTP, 1986). However, another study using a lower dose found no increase in tumors in 
rats (Kociba, 1975 ). Genetic recombination in mammalian cells and the formation of 
macromolecular adducts in rats tissues were observed in rodent studies with exposure to 
the lower molecular weight PBDE in pentaBDE (Helleday, 1999) (Orn, 1998). Thus, 
PBDEs may also be carcinogenic (McDonald, 2002).  
 
From human research studies, PBDEs are suggested to cause adverse effects on 
reproduction, thyroid hormone homeostasis, and neurodevelopment in children. In a 
study measuring women’s fertility with PBDE exposures, prolonged pregnancy time was 
associated with increasing PBDE concentrations in serum of women (n=223) (Harley, 
2010). Increasing thyroid hormone levels in human subjects was also associated with 
increasing PBDE levels in several studies. In a study where the researcher measured 
PBDE concentrations in serum and thyroid hormone levels of a cohort of 140 pregnant 
women, positive associations were observed between PBDE and T4. In two other studies, 
increasing PBDE exposure was associated with rising concentrations of T4 in non-
pregnant women cohorts [Meeker 2009, Turyk 2008]. A negative association of PBDE 
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and thyroid stimulating hormones (TSH) was also observed in one study (Harley, 2010). 
Considering these effects on thyroid hormone regulation, sensitive populations may be 
pregnant women and developing infants.  
 
In one epidemiology study researchers measured the concentrations of PBDE in blood of 
the mothers and children and observed a negative association between PBDEs and test 
scores in both mental and physical development (Herbstman, 2010). In a study on healthy 
women from central Taiwan, researchers found a negative association between PBDEs in 
breast milk and unfavorable birth outcomes such as reduced birth weight and birth length 
of infants (Chao, 2007). In another study in California, serum PBDE were negatively 
linked to the neurodevelopmental function of children, including assessments of 
attention, movement and cognition. PBDEs was were also found to be positively 
associated with increasing attention and motor coordination problems and reduced IQ 
(Eskenazi, 2013). 
 
OPFR health concerns 
According to several animal studies, exposure to OPFRs is associated with adverse 
effects on reproduction and neurodevelopment. In an in vitro study, TPP was observed to 
activate enzymes that regulate steroid hormones (Honkakoski P, 2004). In a study on rats, 
an association of TPP exposure with reproductive effects like reduced fertility was 
observed (Latendresse, 1994).  
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In human studies, OPFR concentrations in the residential indoor dust were negatively 
associated with thyroid hormone levels in men (Meeker, 2010).  A positive relationship 
between TDCPP and TPP with prolactin, a protein that regulates reproduction, 
metabolism and homeostasis of immune response, was also observed (Meeker, 2010). As 
stated previously, hormones are critical for development. In addition, thyroid hormones 
regulate a series of essential physiologic processes in human such as cardiac output, basal 
metabolic rate, endometrium thickening in females and metabolism of proteins and 
carbohydrates (Gelfand, 1987). Selected toxicity effects of some flame retardants with 
effective doses are listed in Table 1.  
 
Project Goals 
In this project, the use of flame retardant additives, and their potential exposure in health 
care settings was examined. The goal of this study was to investigate the potential use of 
flame retardant chemicals in products common to health care settings, and provide 
information on the relative hazards of the chemicals to help health care managers make 
more informed decisions.  This was to be accomplished by conducting a survey of 
manufacturers marketing items common to most medical centers, such as hospital beds, 
and patient cubicle curtains, collecting data on the types of chemicals used by these 
manufactures and/or information on how they meet flammability standards in their 
products. However, a majority of the manufactures that were conducted were reluctant to 
provide information for this survey. As an alternative approach samples from health care 
settings were sampled and tested for flame retardant chemicals, including samples of 
polyurethane foam from hospital furniture products, and dust samples collected from 
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hospitals across the country.   This report was prepared for Health Care without Harm 
(HCWH) and Healthier Hospital Initiative (HHI), who have helped to sponsor and 
support this project.  
Materials and methods 
Literature review and surveys 
A literature review was first conducted to collect information on flame retardant 
applications in different products, especially those that are commonly used in health care 
settings, like hospital interior furnishings. Products containing polyurethane foam were a 
focal point because several reports indicate that foam is often chemically treated to meet 
flammability standards.  Based on the list of manufacturers provided by HCWH, a list of 
18 manufacturers (Appendix I) were prepared. Requests for survey responses were 
initially conducted by email, and then followed up by a phone interview. The survey 
primarily requested information about chemical applications used in products to meet 
different types of flammability standards (e.g.CA TB 117). In addition, the manufacture 
was asked whether they would like their response to be kept confidential, and not 
disclosed in any public documents A copy of the survey questionnaire can be found in 
Appendix II. Surveys were conducted in June-July 2013.  
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Chemical Analyses 
Sample collection  
Due to limited information from manufacturers, more focus was placed on chemical 
analyses of products used in health care settings. Samples of polyurethane foam were 
collected from an infant incubator (n=1), baby beds (n=2), hospital beds in use (n=1), 
hospital bed in surplus (n=1), and sofas (n=2) present in the Duke University surplus 
center (Durham, NC), where the hospital surpluses many of their old or discarded items. 
In addition, in cooperation with HCWH, dust samples from 15 health care settings across 
the country were collected and shipped to Dr. Heather Stapleton’s laboratory at Duke 
University. A list of the health care centers that provided dust samples for this study are 
provided in appendix III.  
 
Chemical analyses  
Detailed sample extraction and analysis methods and techniques can be found in 
Stapleton et al 2012 and Stapleton et al 2014. Briefly, small foam samples were cut out of 
the hospital furniture to be tested. All foam samples were wrapped in aluminum foil and 
stored at room temperature until analysis. Approximately 1 cm3 foam samples were used 
for an initial screening analysis to determine if, and what type, of flame retardant 
chemical was present in the foam. If a flame retardant was identified, a secondary 
analysis was conducted in which a second piece of foam (around 1 cm3) was cut out and 
its mass recorded. Accelerated solvent extraction (ASE) with dichloromethane was used 
to extract FRs from the foam. After a 100-fold dilution of the extract, samples were 
analyzed by gas chromatography-mass spectrometry (GC-MS) for quantification of flame 
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retardants. Dust samples from vacuum bags were first sieved to 500 µm using a stainless 
steel sieve. Hexane and di-chloromethane (50:50) were used to extract chemicals in the 
dust samples. The extracts were concentrated to 1 mL in hexane and solid phase 
extraction (SPE) was applied to eliminate impurities in the extracts.  PBDEs and OPFR 
were elued separately during the SPE step into two fractions. PBDE were quantified 
using gas chromatography mass spectrometry (GC/MS) operated in negative chemical 
ionization mode (GC/ECNI-MS) and OPFRs were quantified using GC/MS in electron 
ionization mode (GC/EI-MS).   
 
QA/QC 
Detailed quality control procedures can be found in Stapleton et al 2012 and Stapleton et 
al 2014. Laboratory blanks, replicate samples (n=6), standard dust reference material 
(SRM 2585; NIST, Gaithersburg, MD) and labeled internal standards were used for data 
quality control. In the dust analyses, samples were divided into three batches, in which 
each batch contained one laboratory blank and one SRM sample. All the measured values 
in the samples were compared to the reported SRM values for quality control.  Average 
blank levels were subtracted from FR levels in samples. Method detection limit (MDL) 
was three times of the standard deviation of the laboratory blank levels. Dust samples 
with concentrations less than MDL were assigned a value of ½ MDL.   
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Results and observations 
Manufacturer Surveys 
Surveys were conducted with the assistance of Ms. Noelle Wyman, an associate 
in the research translation core of Duke’s Superfund Research Center. 19 manufacturers 
were contacted about the use of flame retardants using the questionnaire. The survey was 
first conducted by email. With a zero response rate from email solicitations, a request for 
a phone interview was then employed. During the phone survey, the number for customer 
service was used first. Generally, customer service representatives knew little about the 
application of flame retardants and they forwarded us to sale managers or information 
department; some representatives also suggested we search for information and request 
samples using their website. 
 
From the questionnaire, eight people from six companies replied. Three companies were 
unwilling to reveal their names in the report, and thus C1, C2 and C3 are assigned as their 
aliases. The remaining companies were Pallas, Carnegie Fabric, and Architex. All six 
companies produce cubicle curtains while Pallas, Architex and C3 also produce chairs 
and sofas for hospitals. A question about the use of polyurethane foam was asked since 
polyurethane foam is a common filler material with high flammability, leading to higher 
application rates of flame retardants. However, all companies reported that no 
polyurethane foam was used in their products. 
 
On the company websites, twelve companies listed fire resistance as one of the 
characteristics for safer products, in which six companies listed the specific fire 
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protection standards their products met. NFPA 701 (National Fire Protection Association) 
is the flammability standard most companies conformed to. Other standards include CA 
117 (CA Bulletin), NFPA 260, and UFAC Class 1(Upholstered Furniture Action 
Council). Information about how the products meet the flammability standards is 
summarized in Table 2.  
 
As to the reason why the specific chemicals were used, Architex indicated that chemicals 
are applied at the mill so the company does not make the decisions. C2 indicated that it is 
for human and environmental health concerns while C3 used the chemicals because of 
product performance. Four companies (Architex, C1, C2 and C3), indicated that they 
used flame retardants, and three companies (Architex , C2 and C3) have  changed the 
flame retardant chemicals (like changing the formula) due to potential health impacts. 
The change included changing the chemical formula, like using non-brominated or non-
halogenated flame retardants, or using non-toxic materials with inherent flame resistance 
properties.  
 
Regarding customers’ concerns over flame retardants, three companies have received 
calls expressing concerns about health impacts of these chemicals while one company 
received calls about concerns over the fire resistance performance of the product. 
However, both calls were cited as rare situations. Regarding the health concerns, the 
customers wanted to know if there were flame retardants in the products, and if they were 
non-halogenated or halogenated flame retardants.  
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In considering health/toxicity testing of the chemical treatments, three companies stated 
that they do not consider this, but one company said they rely on the finishers or mill to 
make that decision. The other three companies were concerned about the chemical 
ingredients in their products. The guidelines these companies used include LEED 
(Leadership in Energy and Environmental Design) and Greenguard.  
 
Flame Retardant Chemical Analyses  
Analysis of furniture products 
A total of 7 foam samples were collected from an incubator mattress, baby bed, patients’ 
bed and hospital sofas for flame retardant testing. The sample IDs with description of the 
sampled products are listed in Table 3. An initial screening was first made on the foam 
samples for flame retardants additives by running chemical extracts on a GC/MS system. 
Chemicals were identified by comparing the responses to the NIST mass spectral 
database (2005) and by comparison to authentic standards. During the screening, the 
following FRs were identified:  the OPFR such as TDCPP and BFRs such as PBDE, TBB 
and TBPH. The detected chemicals were then quantified. The concentrations (mg/g 
foam) are provided in Table 3. No FR chemicals were detected in the incubator mattress. 
These identified flame retardants are similar to FR treatments identified in residential 
furniture and baby products (Stapleton et al. 2011; 2012). 
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Analyses of dust samples 
Samples of dust were collected in 15 health care setting during the summer of 2013. 
Extracts were analyzed by GC/MS and quantified (ng/g dry dust). Table 4 details the 
summary statistics of the measured concentrations. Both OPFR and brominated FR were 
commonly detected. The four OPFRs detected were TCPP, TDCPP, TCEP and TPP and 
their concentrations ranged from 121 to 9,420 ng/g, 1,640 to 54,100 ng/g, 186 to 5,770 
ng/g and 344 to 38,400 ng/g, respectively. BDE 209 had the highest concentration and 
ranged from 1,030 to 62,800 ng/g. Also detected were the BFRs TBB and TBPH, 
components of FM 550. Total BFR are lower than total OPFR since OPFR are more 
likely a new-use FR following the phase of PBDE, and are also used as plasticizers in 
some building materials and products.  
 
A normality test (Spearman test) was conducted and all chemicals were found not to be 
normally distributed. The distribution is highly skewed to the right. After log 
transformation, all the chemicals were normally distributed. Correlation analyses were 
conducted on the different FR measured in the dust samples. No significant correlation 
(with p value < 0.05) was found between PBDE, OPFR and FM 550. However, 
significant correlation was only found between several BDE congeners. Table 5 shows 
the correlation coefficient for the various BDE congeners.  
 
The chemical concentrations measured in hospital dust were then compared to household 
dust measurements reported in the scientific literature. The median values of household 
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dust from previous research studies are provided in Table 6 along with the median 
concentrations measured in the hospital dust samples. Concentrations in home settings 
are from Dodson, 2012 in which the researchers analyzed dust samples from 16 
households in California in 2011. Except for the large amount of BDE 209 detected in the 
hospital dust, all the other BDE congeners in hospital dust were lower than levels 
previously measured in household dust. Since the major source of BDE209 is polymer 
and organic matrix while source of other pentaBDE congeners is polyurethane foam, the 
higher concentration of BDE209 and lower concentrations of other BDE congeners in 
hospital dust could be an implication of higher density of polymer products. TBB and 
TBPH appear to be higher in hospital dust samples. The median concentrations of total 
TBB and TBPH in hospital dust samples were almost 6 times the amount measured in 
home dust (Dodson, 2012). For the OPFR, TCPP and TCEP concentrations are lower in 
the hospital dust samples while TDCPP appears to be higher, compared to reported house 
dust levels. In general, when comparing concentrations of the FR commercial mixtures 
(e.g. PBDE or FM 550), the measurements in hospital dust are higher. Since most of the 
dust samples in healthcare settings were collected in the waiting area, the higher number 
of furniture items like waiting room chairs or sofas compared to limited pieces of 
furniture in household settings could contribute to the higher concentrations in the 
hospital dust.  
Conclusion and discussion 
With comparison to FR concentration in home settings, people in the sampled 
health care settings may be exposed to higher levels of some flame retardant chemicals. 
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To better assess the exposure rate, the US EPA dust ingestion model was used. In the 
EPA model, 1 to 5 year-old children are assumed to ingest 100-200 mg dust per day on 
average and adults ingest approximately 20-50 mg dust per day. By multiplying the dust 
ingestion rate and the median FR concentrations measured in the hospital dust, the 
exposure rate in health care settings was estimated. The minimum (or maximum) 
exposure is calculated by multiplying the lowest (or highest) dust ingestion rate with the 
minimum (or maximum) flame retardants concentration in the dust. To calculate the 
exposure rate in a most conservative way, which assumed a lowest dust ingestion rate 
(100 mg dust per day for children and 20 mg dust per day for adults), the mean exposure 
rate was calculated by multiplying the minimum dust ingestion rate with the median 
flame retardants concentration in the dust.  
 
Table 7 displays the results of the exposure calculations. The cumulative min, max and 
mean exposure to total FR (including total PBDE, TBB and TBPH and total OPFR) for 
adult was estimated to be 209 ng/day, 47.1 ng/day and 377 ng/day, respectively and for 
children was 898 ng/day, 202 ng/day and 2,710 ng/day, respectively. The mean exposure 
is consistent with reported exposure to household dust, where the mean exposure for 
adult is 325 ng/day for adults and 1,600 ng/day for children (Stapleton, et al., 2009).  
 
By comparing the LOAEL in animal studies and the exposure rate, none of the chemicals 
reached the hazardous level. However, several risk factors should be considered in the 
comprehensive assessment of risk. First, there are uncertainties in translating animal data 
to human health effects. In addition, people in health care settings are likely a more 
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vulnerable population, which includes sick patients, the elderly, pregnant women and 
children. Thus they may be more sensitive to effects than the general population. Thirdly, 
mean values were used to estimate the exposure, however, in the real world, one or two 
hospitals were found to have much higher concentrations than others. People in those 
health care settings could be exposed to a level that may be significantly higher. Thus, 
due to these uncertainties, a conclusion as to whether the FR levels detected in hospital 
dust would pose a health risk or not can not be made.  
 
Lastly, the limited information about the specific settings of the indoor environments 
sampled in these hospitals is also a limitation. The information gathered only includes 
hospital names. More detailed information, including room area, furniture covering area, 
furniture type, the amount of electronic equipment, room building date, furniture 
production date and furniture replacement rate, would be useful in understanding 
potential differences in FR levels among these dust samples. 
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Table 1: Critical effects and LOAEL of long-term exposure to flame retardants 
chemicals. 
 
Hazardous FR Suggested Adverse 
Effects 
Species LOAEL Reference 
PentaBDE Developmental 
neurotoxicity 
Rats 0.6-0.8 mg/kg 
body wt. per 
day 
(Darnerud, 2003) 
 Altered thyroid 
hormone homeostasis 
Rats  
OctaBDE Morphological effects Rats 10 mg/kg 
body wt. per 
day 
(Darnerud, 2003) 
 Fetal toxicity (weight 
decrease, reduced 
ossification and bent 
ribs) 
Rats 2 mg/kg body 
wt. per day 
 Maternal effects Rats 15 mg/kg 
body wt. per 
day 
DecaBDE Effect on kidney 
(thyroid hyperplasia, 
liver enlargement and 
hyaline degeneration ) 
Rats 80 mg/kg 
body wt. per 
day 
(Darnerud, 2003) 
 Carcinogenesis (tumor 
induction) 
Rats 1200 mg/kg 
body wt. per 
day 
TPP No data available    
TCPP No data available    
TDCPP Increase occurrence of 
liver carcinomas 
Rats 5-80 mg/kg 
body wt. per 
day 
(WHO, Flame 
retardants: 
tris(chloropropyl)phosph
ate and tris(2-
chloroethyl)phosphate, 
1998) 
 Increase in relative liver 
weight 
Mice 171 mg/kg 
body wt. per 
day for males; 
62 mg/kg 
body wt. per 
day for 
females 
(Kamata E, 1989) 
TCEP Hippocampal lesisons Rats 44 mg/kg 
body wt. per 
day 
(Matthews HB, 1990) 
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Table 2: How companies meet fire protection standards and if chemicals are used. 
 
Companies How to meet fire protection 
standards 
Chemicals used 
Pallas Fire barriers, interliners, do not use 
flame retardants 
None 
   
Carnegie, 
customer service 
Some are inherent fire resistant 
(like Trevira CS, Polyester fabric), 
some are chemically treated (not 
topical but could be requested by 
certain products) 
Did not indicate 
   
Carnegie, 
director of 
technical service 
For cubicle curtains, all inherently 
fire resistant (like Trevira CS and 
Trevira FR). Flame retardants are 
used in other products. 
None 
   
Architex Chemical flame retardants, fire 
barriers (interliners), some are 
inherently fire resistant (cubicle 
curtains are inherently flame 
retardant, for upholstery, 50% is 
inherently flame retardant and 50% 
is chemically treated. 
Do not know. 
(Information is at 
mills’ and patented) 
   
C1 Chemical flame retardants, may be 
some coatings or treatment 
Do not know. 
   
C2 Chemical flame retardants, 
inherently flame retardant material 
is fire like wool and trevira 
Potassium 
Hexaflourozircona 
and Zirconium 
Acetate 
   
C3 Some are inherently flame retard 
while others treated with chemical 
flame retardants (a few upholstery 
and woven wall coverings) 
Phosphrous 
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Table 3: Summary statistics for brominated and organophosphate FR (mg/g foam) in 
furnishings. 
 
Foam samples Total PBDE FM 5501 TDCPP2 
F1 Baby bed1 / 18.8 / 
F2 Baby bed2 / 15.1 / 
F3 Incubator mattress / / / 
F4 Sofa1 13.7 / / 
F5 Sofa2 12.9 / / 
F6 Patient bed in surplus 36.2 / / 
F7 Patient bed in use / / 29.0 
 
1. Concentrations of TBB and TBPH were calculated as FM 550, which represents approximately 50% of 
FM 550;  
2. TDCPP is a type of OPFR.    
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Table 4: summary statistics for brominated and organophosphate FR (ng/g dry dust) in 
dust samples. 
 
%detected min max 
Geome
an 
Percentile 
10th 25th 50th 75th 90th 
BDE 28,33 96.6 0 35.9 35.9 2.03 4.43 10.1 26.4 106 
BDE47 100.0 25.8 2740 440 49.1 81.2 243 592 863 
BDE100 100.0 2.72 666 87.4 7.42 14.9 38.5 136 181 
BDE99 100.0 17 8740 1,340 91.6 223 425 1,840 3,580 
BDE154 100.0 0.92 349 67 4.63 12.3 39.8 98.1 132 
BDE153 100.0 3.67 433 91 8.99 20.9 75.2 128 175 
BDE209 100.0 1,030 62,800 8,750 1,550 2,150 6,730 9,820 12,500 
TBB 100.0 56.9 1,990 369 79.5 123 204 291 826 
TBPH 94.1 0 11,300 2,460 439 918 1,610 3,460 4,070 
Total 
PBDE  1,080 75,800 10,800 1,710 2,500 7,560 12,600 17,600 
Total 
Br-FR  1,140 89,100 13,600 2,230 3,540 9,370 16,400 22,500 
          
TCEP 100 186 5,770 1,070 243 537 726 1,170 1,910 
TDCPP 100 1,640 54,100 6,720 1,940 2,430 4,640 6,420 9,700 
TCPP 100 121 9,420 2,340 698 986 1,760 2,890 4,170 
TPP 100 344 38,400 7,770 782 2,630 3,530 6,860 19,100 
Total 
OPFR 
 
2,290 108,000 17,900 3,670 6,580 10,700 17,300 34,800 
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Table 5: A correlation matrix for PBDEs in dust. 
 
BDE 28,33 BDE 47 BDE 100 BDE 99 BDE 154 BDE 153 BDE 209 
BDE.28.33 1 
      BDE.47 0.69* 1 
     BDE.100 0.49* 0.83* 1 
    BDE.99 0.4 0.65* 0.66* 1 
   BDE.154 0.62* 0.95* 0.8* 0.53* 1 
  BDE.153 0.51* 0.85* 0.74* 0.48* 0.87* 1 
 BDE.209 0.61* 0.51* 0.36 0.19 0.49 0.47 1 
 
Values with * are with p value less than 0.05 
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Table 6: Comparison levels in health care to levels (ng/g dry dust) in household.  
 
 Hospital dust  Household dust 
 
Geometric 
mean Median Median 
BDE47 440 243 1,000 
BDE100 87.4 38.5 240 
BDE99 1,340 425 1,100 
BDE154 67 39.8 110 
BDE153 91 75.2 150 
BDE209 8,750 6,730 1,200 
Total PBDE 10,800 7,550 3,800 
    
TBB 369 204 100 
TBPH 2460 1,610 260 
FM 550 2,830 1,810 360 
    TCPP 2,340 1,760 2,200 
TDCPP 6,720 4,640 2,100 
TCEP 1,070 726 2,700 
Total OPFR 10,100 7,130 7,000 
 
Household dust concentrations from (Dodson, 2012). 
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Table 7: Estimated exposure rate (ng/day) for adults and children in health care settings. 
 
 
Adult 
 
Children 
Min Max Mean  Min Max Mean BDE47 1 137 10.7  5 548 46.1 BDE100 0.1 33 1.84  0.3 133 7.89 BDE99 1 437 23.1  5.1 1,750 99.2 BDE154 0 18 1.46  0.1 70 6.24 BDE153 0.1 22 2.34  0.4 87 10 BDE209 16.5 3,090 170  82.4 12,400 729 Total PBDE 18.7 3737 209  93.3 14988 898 
        TBB 0.6 100 5.88  3.2 398 25.2 TBPH 1.3 555 41.3  6.5 2,220 177 FM550 1.9 655 47.2  9.7 2618 202 
        TCEP 3.7 289 27.6  18.6 1,150 118 TDCPP 32.8 2,710 157  164 10,800 674 TCPP 2.4 471 55  12.1 1,880 236 TPP 6.9 1,920 137  34.4 7,680 587 Total OPFR 45.8 5,390 376  229 21,500 1,620 
        Total FR 66 9,770 633  332 39,100 2,710  
For adults, minimum (or maximum) exposure was calculated by multiplying the minimum (or maximum) 
flame retardant concentrations with the minimum dust ingestion rate, 20 mg dust per day (or 50 mg dust per 
day); mean exposure was calculated by multiplying the mean flame retardant concentrations with the 
median dust ingestion rate (35 mg dust per day); 
For children, minimum (or maximum) exposure was calculated by multiplying the minimum (or maximum) 
flame retardant concentrations with the minimum dust ingestion rate, 100 mg dust per day (or 200 mg dust 
per day); mean exposure was calculated by multiplying the mean flame retardant concentrations with the 
median dust ingestion rate (150 mg dust per day). 
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Appendix I: The list of located manufacturers for the survey 
 
Manufacturer Phone number Webpage Products / material 
Architex 800-621-0827 www.architec-ljh.com Upholstery / 
Polyurethane 
Brite, Inc 800-791-2946 www.briteinc.com Cubicle curtains / 
Textiles 
Canegie Fanbrics 800-727-6770 www.canegiefabrics.c
om 
Upholstery / 
Polyurethane 
CF Stinson 800-841-6279 www.cfstinson.com Upholstery / 
Polyurethane face 
DesignTex 800-221-1540 www.dtex.com Upholstery / 
Polyurethane 
Draeger 704-796-1378 no website Mattress / Foam 
Herman Miller1,2 888-443-4357 www.herman 
miller.com 
Furniture / Textiles 
Hill-Rom2 704-737-3566 
919-426-7673 
www.hill-rom.com Furniture: beds hrc.serviceparts@hill-­‐rom.com 
Hospi-Tel 800-678-7100 www.hospitel.com Shower curtains / 
Textiles 
Stryker 941-234-8699 www.stryker.com Furniture: beds, recliners 
Hinkel, Inc.2 704-283-5919 
704-282-0088 
704-996-6904 
www.hinkelinc.com info@hinkelinc.com Curtains / Textiles 
InPro Corporation2 704-615-5794 
704-287-5522 
888-715-8390 
www.inprocorp.com rblankenburg@inprocorp.com	  Ric	  Blankenburg 
Curtains / Textiles 
Maharam 800-645-3943 www.maharam.com Upholstery / 
Polyurethane 
Momentum Textiles 800-366-6839 www.themomgroup.co
m 
Upholstery / 
Polyurethane 
Pallas 800-472-5527 www.pallastextiles.co
m 
Upholstery / 
Polyurethane 
Steelcase 800-333-9939 www.steelcase.com Furniture / Foams, 
textiles 
Teknion 877-835-6466 www.teknion.com Furniture / Foams, 
textiles 
Ultrafabrics 914-460-1730 www.ultrafabrics.com 
sales@ultrafabrics.co
m 
Upholstery / 
Polyurethane 
 
1: companies indicating that their products are not flame retardants free or companies offering no 
information regarding flame retardants;  
2: companies with which DUHS purchase hospital equipment. 
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Appendix II: Questionnaire to manufacturers in health care products 
 
Thank you for participating in our research on the use of flame retardants in health care 
settings. Data collected will be used for Zhouyuan Chen's master's project at the Nicholas 
School of the Environment at Duke University. Information gathered for this research 
will be written in a publicly-available report. You may choose to remain anonymous in 
the final report. We anticipate that this project, and the final report, will be completed in 
one year. 
Contact information:  
Zhouyuan Chen, Master of Environmental Management candidate 
Phone: 919-813-8032 
Email: zhuoyuan.chen@duke.edu 
Noelle Wyman, Research Assistant 
Phone: 919-684-3159 
Email: noelle.wyman@duke.edu 
 
Date:________________     
 
Company Name:_______________________ 
Name________________________________   
Phone________________________________ 
 
Questions: 
 
1. Which of the following products does your company sell to health care 
organizations (e.g. hospitals, clinics, etc)? Please check all that apply. 
 Chairs or Sofas                                   
 Cubicle curtains/drapes for patients 
        Baby/infant mattresses                      
             Patient Beds/mattresses 
 
2. Which products contain polyurethane foam?  
(You may include the specifications (e.g. label or model names or specific name) 
of the products, if applicable in question 2(a).)  
 Chairs                                 
 Sofas 
 Baby/Infant Mattress 
 Patient Beds/mattress 
 No products 
 Others:____________________________ 
 
2(a) Models of the product (if applicable) 
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3. If you sell products that meet state or federal flammability standards, how do you 
meet those standards? 
 Chemical flame retardants 
 Fire barrier (interliners)    
 No materials are chemically treated                    
 Others__________________________________    
 
3. (a) If your products are treated with flame retardant chemicals, please note 
which products are chemically treated. 
 
 
3. (b) Which types of chemicals are used most frequently? 
 
 
4. If your products are treated with flame retardant chemicals, can you tell us why 
this specific chemical was chosen? 
 Affordability/Cost     
 Availability 
 Performance      
 Don’t know 
 We do not use flame retardants chemicals 
 Other______________________________________________________ 
5. Do you know which company provides the polyurethane foam for your products? 
 Yes, and they are 
__________________________________________________ 
 No, I don’t know. 
 Not applicable 
       I prefer not to answer 
6.  Have you ever received calls or emails from customers concerned with the use of 
flame retardant chemicals in your products?  
 Yes                                        
       No  
       Not applicable 
If yes, approximately how many calls/emails?_________________________ 
If yes, what were the primary concerns?  
7. Does your company review or consider any available health/toxicity testing 
information/data on these chemical treatments before you use them in your 
products?   
 Yes                                        
 No 
 Not applicable 
Why or Why Not? 
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8. Has your company ever changed the flame retardant chemicals in your products 
or the method for achieving a state or federal flammability standard due to 
concerns about potential public health concerns?   
 Yes                                     
 No  
 Not applicable 
If yes, what prompted that decision? 
9. We would like to list all the companies that participated in this survey in our 
publicly-available final report. May we publish the name of your company in our 
final report. (If you choose no, your responses will be anonymous in the final 
report.)  
 Yes 
 No 
 
10. May we publish information on specific products your company sells that are 
treated with flame retardants and which you report to us in this survey? (If you 
want to publish only a part of the information, please indicate in other.) 
 Yes, all information provided in this survey can be published in your report. 
 Yes, but only report on products that meet specific flammability standards 
(e.g. TB 133) without listing which chemical ingredients are used. 
 No, I don’t want to publish any of the information. 
 Not applicable because our products do not contain chemical flame retardants. 
 Other: 
_____________________________________________________________. 
 
Thank you for your time. 
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Appendix III: Hospitals where dust samples were collected 
 
Hospital 
ID Number 
Hospital name State Date collected 
1 Michigan Hospital Michigan 6/24-27/13 
2 California California 6/25/13 
3 Mercy Gilbert Medical Center Arizona 6/27/13 
4 French Hospital California 6/28/13 
5 
 
Methodist Hospital 1st floor California 
 
7/1/13 
Methodist Hospital 2nd floor 
Methodist Hospital 3rd floor 
Methodist Hospital 4th floor 
6 Mcgee Womens Hospital, 
old carpet in clinic 
California 6/29/13 
Mcgee Womens Hospital, 
new carpet in clinic 
7 Mercy San Juan Medical 
Center, 
public areas 
California 6/13/13 
Mercy San Juan Medical 
Center, 
patient area 
8 CHWST Mary's Medical Center 
(hallways, waiting rooms, 
offices) 
California 7/2/13 
9 Fletcher Allen Health Care Vermont Aug. 2013 
10 UM Mott Children's Hospital, 
7th floor east side 
Michigan 7/31/13 
UM Mott Children's Hospital, 
3rd floor on-call area 
11 UCSF Medical Center, 
Pedi clinic, Post St. 3rd floor 
California  
UCSF Medical Center, 
L-Adult patient rooms, 1st floor 
12 Condell Medical Center Illinois 7/9/13 
13 California Hospital California 9/11/13 
14 Duke Clinic Cancer center North 
Carolina 
July, 2013 
15 Duke South North 
Carolina 
July, 2013 
 
 
